Sokal, Hasford, and EUTOS scores
CML - Chronic myeloid leukemia
ARTICLES
ACE-27 Score Has Prognostic Potential in Chronic Phase Chronic Myeloid Leukemia
December 14, 2021, Oncology Nurse Advisor
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
August 19, 2021, Leukemia
The EUTOS Long-Term Survival (ELTS) Score Is Superior to the Sokal Score for Predicting Survival in Chronic Myeloid Leukemia
June 29, 2020, PubMed
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
July 8, 2018, Dove Press
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India
2016, ecancermedicalscience
Sokal Risk Score Is Superior to Hasford and EUTOS in Determining Survival Outcomes for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
December 3, 2015, ASH Publications
ACE-27 Score Has Prognostic Potential in Chronic Phase Chronic Myeloid Leukemia
December 14, 2021, Oncology Nurse Advisor
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?
August 19, 2021, Leukemia
The EUTOS Long-Term Survival (ELTS) Score Is Superior to the Sokal Score for Predicting Survival in Chronic Myeloid Leukemia
June 29, 2020, PubMed
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
July 8, 2018, Dove Press
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India
2016, ecancermedicalscience
Sokal Risk Score Is Superior to Hasford and EUTOS in Determining Survival Outcomes for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
December 3, 2015, ASH Publications